Published online Jun 26, 2021. doi: 10.12998/wjcc.v9.i18.4644
Peer-review started: December 19, 2020
First decision: January 23, 2021
Revised: January 23, 2021
Accepted: March 17, 2021
Article in press: March 17, 2021
Published online: June 26, 2021
Processing time: 171 Days and 1.1 Hours
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) are alternatives for ovarian cancer. Delayed gastric emptying (DGE), a common complication of this procedure, can cause discomfort and decrease quality of life postoperatively. However, little attention has been given to this complication.
Though not life-threatening, DGE can increase the duration of postoperative hospitalization, decrease quality of life, and even affect the long-term prognosis of patients after CRS-HIPEC. More research is needed to elucidate the pathophysiology, etiology and treatment of DGE.
The aim of this study was to identify the risk factors for DGE in patients with ovarian cancer treated with CRS-HIPEC. Identifying patients at increased risk for DGE may aid patient selection as well as postoperative gastrointestinal management.
A retrospective study was conducted, and risk factors for DGE were analyzed using univariate and multivariate analyses.
Age ≥ 70 years and intraoperative hemorrhage ≥ 800 mL were independently associated with postoperative DGE after CRS-HIPEC. Perigastric and gastric dissection is known to be the greatest risk factor for DGE. However, it was not found to be related to DGE in our study. The possible reason may be that the sample size was too small.
Postoperative gastrointestinal management, including prolonged nasogastric intubation, should be strengthened for patients over 70 years or with intraoperative bleeding exceeding 800 mL.
Large-sample RCTs are needed to further identify the risk factors and management of DGE.